Robert Carlson Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Portfolio
  • 1

Robert Carlson General Information

Description

Dr. Robert Carlson serves as Managing Director at Bioeconomy Capital. He also serves as Board Member at Lumen Bioscience, RoosterBio, and Parse Biosciences. He serves as Board Observer at Cyclic Materials and Tandem PV. He is an Angel Investor. He is an entrepreneur, author, and scientist. The namesake of "Carlson Curves" and originator of the first estimates of global biotech revenues. He is the author of the book Biology is Technology: The Promise, Peril, and New Business of Engineering Life, published in 2010 by Harvard University Press; it received the PROSE award for the Best Engineering and Technology Book of 2010 and was named to the Best Books of 2010 lists by writers at both The Economist and Foreign Policy. He earned a doctorate in Physics from Princeton University in 1997.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • 3417 Evanston Avenue North
  • Suite 329
  • Seattle, WA 98103
  • United States
+1 (415) 000-0000

Robert Carlson Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
RoosterBio 30-Dec-2014 00000 00000 00.000 Biotechnology Generating Revenue

Robert Carlson Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Robert Carlson Team (1)

Name Title Deals Funds Boards Office
Robert Carlson Ph.D Angel Investor 0 0 0 Seattle, WA

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »